论文部分内容阅读
目的:探讨布地奈德联合特布他林雾化吸入治疗小儿喘息型支气管炎的临床疗效。方法:选取2015年7月-2016年7月在医院接受治疗的72例小儿喘息型支气管炎患儿作为此次研究对象,给予患儿药物治疗,并根据药物的不同分为观察组与对照组,每组患儿36例,对照组患儿给予口服硫酸沙丁胺醇片治疗,观察组患儿给予布地奈德联合特布他林雾化吸入治疗,对两组患者的各项症状进行观察并记录,分析比较两组患儿症状、体征缓解时间情况、临床疗效情况。结果:观察组患儿咳嗽、咯痰、喘憋、哮鸣音、门诊时间等相比于对照组,观察组明显更低,观察组患儿总有效率为97.22%相比于对照组的83.33%,观察组明显更高,组间比较,差异具有统计学意义(P<0.05)。结论:布地奈德联合特布他林雾化吸入治疗小儿喘息型支气管炎的临床疗效显著,患儿的症状和体征得到了明显改善,治愈率得到了明显提升,临床上值得推广应用。
Objective: To investigate the clinical efficacy of budesonide combined with terbutaline in nebulization in the treatment of asthmatic bronchitis in children. Methods: Seventy-two infants with asthmatic bronchitis who were treated in the hospital from July 2015 to July 2016 were selected as the study subjects and were given drug treatment. According to the different drugs, they were divided into observation group and control group , 36 children in each group, children in the control group were treated with salbutamol sulphate orally. The children in the observation group were treated with inhalation of budesonide combined with terbutaline. The symptoms of the two groups were observed and recorded. Analysis of two groups of children with symptoms, signs of remission time, clinical efficacy. Results: Compared with the control group, the observation group was significantly lower in the observation group of cough, expectoration, wheezing, wheeze, outpatient time, the total effective rate was 97.22% in the observation group compared with 83.33 in the control group %, The observation group was significantly higher, compared between groups, the difference was statistically significant (P <0.05). Conclusion: The clinical efficacy of budesonide combined with terbutaline as nebulized inhalation in the treatment of infantile asthmatic bronchitis is significant. The symptoms and signs of children have been significantly improved, the cure rate has been significantly improved, which is worth popularizing and applying clinically.